Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis

Ophthalmology

Volumn 107, Issue 5, 2000, Pages 877-881

  Macdonald, J Christopher ^a,f   Karavellas, Marietta P ^b   Torriani, Francesca J ^c   Morse, Lawrence S ^d   Smith, Irene L ^e   Reed, J Brian ^d   Freeman, William R ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CIDOFOVIR; GANCICLOVIR; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; LYMPHOCYTE COUNT; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINITIS; TREATMENT FAILURE; VIRUS LOAD;

EID: 0033796369     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00023-3     Document Type: Article

References (20)

1. R.M. Gulick J.W. Mellors D. Havlir Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy N Engl J Med 337 1997 734 739
2. C. Michelet C. Arvieux C. Francois Opportunistic infections occurring during highly active antiretroviral treatment AIDS 12 1998 1815 1822
3. J.G. Gross S.A. Bozzette W.C. Mathews Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome Ophthalmology 97 1990 681 686
4. Studies of Ocular Complications of AIDS (SOCA). Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Ann Intern Med 1997;126:264–74.
5. M.A. Jacobson Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome N Engl J Med 337 1997 105 114
6. J.P. Lalezari B.D. Kuppermann Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis J Acquir Immune Defic Syndr Hum Retrovirol 14 Suppl 1 1997 S27 S31
7. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med 1995;155:65–74.
8. J.C. Macdonald J.T. Torriani L.S. Morse Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy J Infect Dis 177 1998 1182 1187
9. C. Tural J. Romeu G. Sirera Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients J Infect Dis 177 1998 1080 1083
10. D.A. Jabs S.G. Bolton J.P. Dunn A.G. Palestine Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy Am Ophthalmol 126 1998 817 822
11. T.R. Vrabec V.F. Baldassano S.M. Whitcup Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts Ophthalmology 105 1998 1259 1264
12. S.M. Mitchell W.L. Membrey M.S. Youle Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy a 2 year prospective study Br J Ophthalmol 83 1999 652 655
13. Kirsch LS, Arevalo JF, Chavez de la Paz E, et al. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1995;102:533–42; discussion 542–3.
14. G.N. Holland W.C. Buhles Jr B. Mastre H.J. Kaplan A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy Study Group Arch Ophthalmol 107 1989 1759 1766
15. W.L. Drew D. Ives J.P. Lalezari Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group N Engl J Med 333 1995 615 620
16. M.A. Jacobson M. Zegans P.R. Pavan Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy Lancet 349 1997 1443 1445
17. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. N Engl J Med 1992;326:213–20.
18. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Ophthalmology 1994;101:1250–61.
19. L. Perrin A. Telenti HIV treatment failure testing for HIV resistance in clinical practice Science 280 1998 1871 1873
20. M. Flores-Aguilar D. Munguia G. Besen Clinical versus fundus photographic evaluation of the status of cytomegalovirus retinitis in AIDS patients Retina 16 1996 363 372